Prevention
By Mayo Clinic staffThere is no known way to prevent sporadic CJD from developing. If you have a family history of neurological disease, you may benefit from talking with a genetics counselor, who can help you sort through the risks associated with your particular situation.
Caregivers
If you're caring for someone with CJD or vCJD, the National Institutes of Health recommend the following basic precautions:
- Wash your hands and exposed skin before eating, drinking or smoking.
- Protect your hands and face from exposure to the person's blood or fluids.
- Cover cuts or wounds with waterproof bandages.
Preventing iatrogenic CJD
Hospitals and other medical institutions follow explicit policies to prevent iatrogenic CJD. These measures have included:
- Exclusive use of synthetic human growth hormone, rather than the kind derived from human pituitary glands
- Destruction of surgical instruments used on the brain or nervous tissue of someone with known or suspected CJD
- Single-use kits for spinal taps (lumbar punctures)
You could contract CJD from an organ transplant if the donor was in the incubation stage of the disease and not yet showing signs and symptoms. However, this scenario is very unlikely. The benefits obtained from an organ transplant are generally much greater than the risk of contracting CJD.
To help ensure the safety of the blood supply, people with a risk of exposure to CJD or vCJD aren't eligible to donate blood. This includes people who:
- Have a biological relative who has been diagnosed with CJD
- Have received a dura mater brain graft
- Have received human growth hormone
- Spent a total of at least three months in the U.K. from 1980 to 1996
- Spent five years or more in France from 1980 to the present
- Received a blood transfusion in the U.K. between 1980 and the present
- Have injected bovine insulin at any time since 1980
Preventing vCJD
The risk of contracting vCJD in the United States remains extremely low. So far, a total of three cases have been reported in the U.S. According to the Centers for Disease Control and Prevention, strong evidence suggests that these cases were acquired abroad — two in the United Kingdom and one in Saudi Arabia.
In the United Kingdom, where the majority of vCJD cases have occurred, fewer than 200 cases have been reported. After its first appearance in 1995, CJD incidence peaked between 1999 and 2000, and has been declining since.
Regulating potential sources of vCJD
Most countries have taken steps to prevent BSE-infected tissue from entering the food supply, including tight restrictions on importation of cattle from countries where BSE is common; restrictions on animal feed; strict procedures for dealing with sick animals; surveillance and testing methods for tracking cattle health; and restrictions on which parts of cattle can be processed for food.
The risk of vCJD from the following sources is estimated to be extremely low:
- Vaccines. Some parts of cows, including blood, enzymes and amino acids, are used to grow the bacteria and viruses needed to make certain vaccines. Not all vaccines are grown in cattle parts, however, and the Food and Drug Administration (FDA) recommends that companies producing such vaccines use cattle parts only from low-risk countries. These recommendations apply to cosmetics as well. The FDA keeps a listing on its Web site of companies that use cattle from countries that aren't classified as low-risk.
- Insulin. Insulin sold in the United States isn't derived from cattle, but you're allowed to import beef insulin from other countries if you follow specific guidelines. Because there's no way to guarantee the safety of imported insulin, talk to your doctor about the best way to obtain insulin from sources outside the United States.
- Creutzfeldt-Jakob disease and other prion diseases. Creutzfeldt-Jakob Disease Foundation. http://www.cjdfoundation.org/documents/aboutcjd.pdf. Accessed March 24, 2010.
- Creutzfeldt-Jakob disease fact sheet. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/cjd/detail_cjd.htm. Accessed March 24, 2010.
- Brown HG, et al. Creutzfeldt-Jakob disease. http://www.uptodate.com. Accessed March 24, 2010.
- Brown HG, et al. Variant Creutzfeldt-Jakob disease. http://www.uptodate.com. Accessed March 25, 2010.
- vCJD (variant Creutzfeldt-Jakob disease). Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvrd/vcjd/factsheet_nvcjd.htm. Accessed March 24, 2010.
- CJD fact sheet. Creuzfeldt-Jakob Disease Foundation Inc. http://www.cjdfoundation.org/. Accessed March 24, 2010.
- vCJD (Variant Creutzfeldt-Jakob disease): Risk for travelers. Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvrd/vcjd/risk_travelers.htm. Accessed March 24, 2010.

Find Mayo Clinic on